StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca EBITDA by Quarter

EBITDA ($M) ($M)

QuarterlyAnnual

AstraZeneca EBITDA: $5,092M in Q2 2026, up 4.0% from a year earlier.

Latest, Q2 2026
5,092
Period ended Jun 30, 2026
Change on a year earlier
+4.0%
4,897 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| EBITDA | 10,705 | | 9,855 | 9 | 7 | | | 5,092 | 4,897 | | 4 | | 1”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F EBITDA Reconciliation Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEBITDA ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20265,092+4.0%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20265,612+13.2%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20254,489+2.7%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20255,132+30.8%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20254,897+21.7%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20254,958+13.5%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20244,373+70.8%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20243,923+21.2%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20244,025+7.9%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20244,370+7.9%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20232,561-0.5%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20233,236+25.5%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20233,732+96.8%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20234,051+85.2%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20222,574+35.5%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20222,579+131.5%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up EBITDA

Cite this data

StockData. (2026). AstraZeneca EBITDA ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rep-ebitda

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.